State of Wyoming’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $102K | Buy |
+4,250
| New | +$102K | 0.01% | 1307 |
|
|
2025
Q1 | – | Sell |
-6,566
| Closed | -$124K | – | 1795 |
|
|
2024
Q4 | $124K | Buy |
6,566
+487
| +8% | +$9.18K | 0.02% | 1079 |
|
|
2024
Q3 | $91.5K | Buy |
6,079
+634
| +12% | +$9.54K | 0.01% | 1216 |
|
|
2024
Q2 | $156K | Buy |
5,445
+423
| +8% | +$12.1K | 0.03% | 758 |
|
|
2024
Q1 | $147K | Buy |
5,022
+3,391
| +208% | +$99.1K | 0.02% | 778 |
|
|
2023
Q4 | $55K | Sell |
1,631
-1,638
| -50% | -$55.3K | 0.01% | 1275 |
|
|
2023
Q3 | $100K | Buy |
3,269
+2,359
| +259% | +$72.4K | 0.02% | 855 |
|
|
2023
Q2 | $36.5K | Buy |
910
+204
| +29% | +$8.17K | 0.01% | 1239 |
|
|
2023
Q1 | $28.8K | Buy |
706
+99
| +16% | +$4.04K | 0.01% | 1301 |
|
|
2022
Q4 | $23.4K | Sell |
607
-1,940
| -76% | -$74.9K | 0.01% | 1333 |
|
|
2022
Q3 | $136K | Buy |
2,547
+612
| +32% | +$32.7K | 0.07% | 414 |
|
|
2022
Q2 | $113K | Sell |
1,935
-476
| -20% | -$27.8K | 0.07% | 424 |
|
|
2022
Q1 | $184K | Buy |
2,411
+99
| +4% | +$7.56K | 0.09% | 234 |
|
|
2021
Q4 | $139K | Buy |
2,312
+209
| +10% | +$12.6K | 0.06% | 416 |
|
|
2021
Q3 | $118K | Buy |
2,103
+376
| +22% | +$21.1K | 0.08% | 362 |
|
|
2021
Q2 | $105K | Buy |
+1,727
| New | +$105K | 0.07% | 431 |
|